5-(4-BROMO-3-METHYLTHIOPHEN-2-YL)-3-(2-CHLORO-6-FLUOROPHENYL)-1-METHYL-1H-1,2,4-TRIAZOLE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	MGJTZTLZUQHCDX-UHFFFAOYSA-N
Smiles	Cc1c(Br)csc1c2nc(nn2C)c3c(F)cccc3Cl
InChI	InChI=1S/C14H10BrClFN3S/c1-7-8(15)6-21-12(7)14-18-13(19-20(14)2)11-9(16)4-3-5-10(11)17/h3-6H,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C14H10BrClFN3S
Molecular Weight	386.67
AlogP	5.4
Hydrogen Bond Acceptor	2.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	2.0
Polar Surface Area	58.95
Molecular species	NEUTRAL
Aromatic Rings	3.0
Heavy Atoms	21.0

Assay Description	Organism	Bioactivity
Insecticidal activity against female Tetranychus urticae (two-spotted spider mite) infested cotton leaf disks followed compound spraying after oviposit assessed as insect mortality measured after 6 days post compound application under green house conditions	Tetranychus urticae	0.29 ppm
Insecticidal activity against Myzus persicae (green peach aphid) assessed as insect mortality at 50 ppm	Myzus persicae	0.8 ppm
Insecticidal activity against Aphis gossypii (cotton aphid) infested one week old Crookneck squash plants assessed as insect mortality measured after 3 days post compound application under green house conditions	Aphis gossypii	0.7 ppm

Cross References

Resources	Reference
ChEMBL	CHEMBL2251643
PubChem	11749519
SureChEMBL	SCHEMBL2933280

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).